Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  HYPERTENSION

• Publication date

  1986-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.8.11.971PMID 3021624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bradykinin competitive antagonists for classical kinin systems.

  1986cited by this paper
• Competitive antagonists of bradykinin.

  1985cited by this paper
• The development of vasopressin antagonists.

  1984cited by this paper
• Role of Kinins in the Acute Antihypertensive Effect of the Converting Enzyme Inhibitor, Captopril

  1981cited by this paper
• Differences in Response to the Peptidyldipeptide Hydrolase Inhibitors SQ 20,881 and SQ 14,225 in Normal‐Renin Essential Hypertension

  1980cited by this paper
• Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.

  1979cited by this paper
• Converting Enzyme Inhibition in Essential Hypertension: The Hypotensive Response Does Not Reflect Only Reduced Angiotensin II Formation

  1979cited by this paper
• Converting Enzyme Inhibitor and Saralasin Infusion in Rats: Evidence for an Additional Vasodepressor Property of Converting Enzyme Inhibitor

  1978cited by this paper
• Accentuated vascular and endocrine response to SQ 20881 in hypertension.

  1977cited by this paper
• Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbits.

  1977cited by this paper
• Urinary Kallikrein in Dogs with Constriction of One Renal Artery

  1976cited by this paper
• Conversion of angiotensin I to angiotensin II.

  1976cited by this paper
• Kininogenase in kidney after ligation of the ureter and after experimental aortic stenosis

  1974cited by this paper
• Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.

  1971cited by this paper
• Role of the Pressor Action of Angiotensin IIin Experimental Hypertension

  1971cited by this paper
• The Effect of the Kinins on the Cardiovascular System

  1970cited by this paper
• Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung

  1968cited by this paper
• Conversion of Angiotensin I to Angiotensin II

  1967cited by this paper
• The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat.

  1967cited by this paper
• A Bradykinin-Potentiating Factor (BPF) present in the Venom of Bothrops jararaca.

  1965cited by this paper
• A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA.

  1965cited by this paper
• Bradykinin as a vasodilator in man

  1961cited by this paper

• Role of Kinins in Hypertension and Heart Failure

  2020cites this paper
• Alcohol Abuse and the Injured Host: Dysregulation of Counterregulatory Mechanisms Review

  2013cites this paper
• Angiotensin-Converting Enzyme Inhibitors or Calcium Channel Blockers?

  2012cites this paper
• The kallikrein-kinin system as a regulator of cardiovascular and renal function.

  2011cites this paper
• Cardioprotective properties of bradykinin: role of the B2 receptor

  2010cites this paper
• Renin angiotensin system and cardiovascular disease

  2010cites this paper
• Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system.

  2009cites this paper
• Kinins and Cardiovascular Disease

  2009cites this paper
• Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors

  2008cites this paper
• Hfiperiensum Laboratory Studies Plasma Kinin Concentration in Deoxycorticosterone-Salt Hypertension

  2005cites this paper
• Methods Experiment 1 : Effect of Chronic ACE Inhibitor Treatment on Cardiac Function and Metabolism

  2005cites this paper
• Chapter 20 – The Kallikrein-Kinin System as a Regulator of Cardiovascular and Renal Function

  2005cites this paper
• Effects of Angiotensin Converting Enzyme Inhibitor Versus Angiotensin II Receptor Blocker

  2005cites this paper
• Angiotensin-Converting Enzyme Inhibition and the Heart

  2005cites this paper
• Endothelial Dysfunction and Role of the Renin-Angiotensin System

  2005cites this paper
• In vivo visualization of subendocardial arteriolar response in renovascular hypertensive hearts.

  2003cites this paper
• Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykinin

  2002cites this paper
• Vasoactive Potential of the B1 Bradykinin Receptor in Normotension and Hypertension

  2001cites this paper
• The role of ACE inhibition in heart failure

  2001cites this paper
• Endothelium and smooth muscle function in rat mesentric vasculature

  2001cites this paper
• Angiotensin-converting enzyme inhibitors.

  2001cites this paper
• Bradykinin, an Important Mediator of the Cardiovascular Effects of Metallopeptidase Inhibitors: Experimental and Clinical Evidences

  2001cites this paper
• Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.

  2000cites this paper
• Measurement of the Renin-Angiotensin System in Heart Failure

  2000cites this paper
• Predicting Response to Chronic Antihypertensive Treatment with Fosinopril: The Role of Angiotensin-Converting Enzyme Gene Polymorphism

  2000cites this paper
• Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review

  2000cites this paper
• The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

  2000cites this paper
• Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men.

  2000cites this paper
• Angiotensin II (Typ-1)-Rezeptorblocker in der Behandlung der chronischen Herzinsuffizienz

  1999influential citation
• Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.

  1999influential citation
• SHORT-TERM EFFECT OF CAPTOPRIL ON INTRAOCULAR PRESSURE.

  1999cites this paper
• Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.

  1999cites this paper
• Pharmacology and cardiovascular implications of the kinin-kallikrein system.

  1999cites this paper
• Mechanisms underlying very-low-frequency RR-interval oscillations in humans.

  1998cites this paper
• Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.

  1998cites this paper
• Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.

  1998cites this paper
• Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed rat.

  1998cites this paper
• Functional effects of endogenous bradykinin in congestive heart failure.

  1998cites this paper
• Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen‐2)27) rats

  1997cites this paper
• Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.

  1997cites this paper
• Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.

  1997cites this paper
• The Pharmacology and Immunopharmacology of Kinin Receptors

  1997cites this paper
• Blood pressure responses to acute or chronic captopril in mice with disruption of bradykinin B2‐receptor gene

  1997cites this paper
• Arterial responses to bradykinin after ramipril therapy in experimental hypertension.

  1997cites this paper
• Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.

  1997cites this paper
• Amplification of kinin-induced hypotension by nitric oxide synthesis in spontaneously hypertensive rats.

  1997cites this paper
• Threonine6-bradykinin: structural characterization in the presence of micelles by nuclear magnetic resonance and distance geometry.

  1997cites this paper
• In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity.

  1997cites this paper
• Nitric oxide and the renin angiotensin system: contributions to blood pressure in the young rat

  1997cites this paper
• Therole ofendogenous bradykinin inblood pressurehomeostasis inspontaneously hypertensive rats

  1996cites this paper
• Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.

  1996cites this paper
• Cardioprotective potential of angiotensin converting enzyme inhibitors.

  1996cites this paper
• The renin-angiotensin system in left ventricular remodeling.

  1996cites this paper
• Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.

  1996cites this paper
• The role of endogenous bradykinin in blood pressure homeostasis in spontaneously hypertensive rats

  1996cites this paper
• Section Review Cardiovascular & Renal: Bradykinin degradation: potential pathways for cardiovascular therapeutic use

  1996cites this paper
• Contribution of nitric oxide to the beneficial effects of enalapril in the fructose-induced hyperinsulinemic rat.

  1996cites this paper
• Threonine6‐bradykinin: Conformational study of a flexible peptide in dimethyl sulfoxide by NMR and ensemble calculations

  1996cites this paper
• THE SPECIFIC BLOCKING OF ANGIOTENSIN II TYPE 1 RECEPTOR PROTECTS THE ENDOTHELIAL FUNCTION IN THE VERY EARLY STAGE OF RENAL HYPERTENSION IN RATS

  1996cites this paper
• Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.

  1996cites this paper
• Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction.

  1996cites this paper
• Cardiovascular hypertrophy: role of angiotensin II and bradykinin.

  1996cites this paper
• Effects of Bradykinin on Short‐Term Variability in Blood Pressure and Heart Rate in Rats: A Spectral Study

  1995cites this paper
• Biochemistry and cell biology of angiotensin-converting enzyme and converting enzyme inhibitors.

  1995cites this paper
• Angiotensin II receptor antagonists in heart failure: Rationale and design of the evaluation of losartan in the elderly (ELITE) trial

  1995cites this paper
• Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

  1995cites this paper
• Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.

  1995cites this paper
• Bradykinin antagonists: Development and applications

  1995cites this paper
• ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS AND KININ METABOLISM: EVIDENCE THAT ACE INHIBITORS MAY INHIBIT A KININASE OTHER THAN ACE

  1995cites this paper
• [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].

  1995cites this paper
• Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis.

  1995cites this paper
• Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.

  1995cites this paper
• Role of kinins in the acute antihypertensive effect of enalapril in hypertensive rats.

  1994cites this paper
• Lack of involvement of the kallikrein-kinin system in the depressor effect of alpha-methyldopa in normotensive rats.

  1994cites this paper
• Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.

  1994influential citation
• Exaggerated vascular response due to endothelial dysfunction and role of the renin-angiotensin system at early stage of renal hypertension in rats.

  1994cites this paper
• Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.

  1994cites this paper
• Pathophysiology of altered renal function in renal vascular hypertension.

  1994cites this paper
• Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition

  1994cites this paper
• Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart.

  1994cites this paper
• Acute and long‐term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters

  1994cites this paper
• Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.

  1993cites this paper
• Endogenous Bradykinin Activity in Dahl Rats

  1993cites this paper
• The kinin system in inflammation.

  1993cites this paper
• New Therapeutic Agents in the Management of Hypertension: Angiotensin II-Receptor Antagonists and Renin Inhibitors

  1993cites this paper
• Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension

  1993cites this paper
• Bradykinin peptides in kidney, blood, and other tissues of the rat.

  1993cites this paper
• The transition from experimental to clinical pharmacology: the renin-angiotensin paradigm.

  1993cites this paper
• Receptor antagonists of bradykinin: a new tool to study the cardiovascular effects of endogenous kinins.

  1993cites this paper
• Urinary kallikrein excretion and blood pressure response to angiotensin converting enzyme inhibitors and calcium antagonists in hypertensive patients

  1993cites this paper
• Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

  1993cites this paper
• The renin-angiotensin paradigm. Practical therapeutical consequences of basic research.

  1993cites this paper
• Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?

  1992cites this paper
• Bradykinin-mediated effects of ACE inhibition.

  1992cites this paper
• Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.

  1992cites this paper
• Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.

  1992cites this paper
• Role of Endothelium‐Derived Bradykinin in the Control of Vascular Tone

  1992cites this paper
• Role of Bradykinin in Chronic Antihypertensive Actions of Rarnipril in Different Hypertension Models

  1992cites this paper
• Blood Pressure Control by the Renin‐Angiotensin System in Normotensive Subjects: Assessment by Angiotensin Converting Enzyme and Renin Inhibition

  1992cites this paper
• Enhanced vasodilatory responses to bradykinin in stroke-prone spontaneously hypertensive rats.

  1992cites this paper